Movement Alert｜Twist Bioscience Corp Falls 9.51% in Regular Trading, Fiscal Q3 Swings to Loss Exceeding Expectations

Market Focus08-03

On August 3, Twist Bioscience Corp declined 9.51% in regular trading, trading at approximately $87.2 per share, with turnover of $23.49 million. The selloff was triggered by the company's fiscal third-quarter earnings report showing a sharp swing from profit to loss.

The company reported a fiscal Q3 net loss of $0.56 per diluted share, swinging from earnings of $0.33 a year earlier. The loss exceeded the analyst consensus estimate of $0.51 per share. On the revenue side, the company posted $118.4 million, up 23.2% year-over-year, beating the $114.5 million estimate. The company also raised its full-year revenue outlook to $456-$457 million from a prior range of $442-$447 million, and guided fiscal Q4 revenue of $123-$124 million versus the $117.4 million consensus.

Despite strong top-line growth and upbeat forward guidance, the deterioration in profitability dominated investor sentiment. Additionally, Evercore ISI had downgraded the stock from Outperform to In Line in early July, reflecting prior concerns about near-term earnings trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119962251?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119962251","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Falls 9.51% in Regular Trading, Fiscal Q3 Swings to Loss Exceeding Expectations","media":"Market Focus","content":"<p><p>On August 3, Twist Bioscience Corp declined 9.51% in regular trading, trading at approximately $87.2 per share, with turnover of $23.49 million. The selloff was triggered by the company's fiscal third-quarter earnings report showing a sharp swing from profit to loss.</p><p>The company reported a fiscal Q3 net loss of $0.56 per diluted share, swinging from earnings of $0.33 a year earlier. The loss exceeded the analyst consensus estimate of $0.51 per share. On the revenue side, the company posted $118.4 million, up 23.2% year-over-year, beating the $114.5 million estimate. The company also raised its full-year revenue outlook to $456-$457 million from a prior range of $442-$447 million, and guided fiscal Q4 revenue of $123-$124 million versus the $117.4 million consensus.</p><p>Despite strong top-line growth and upbeat forward guidance, the deterioration in profitability dominated investor sentiment. Additionally, Evercore ISI had downgraded the stock from Outperform to In Line in early July, reflecting prior concerns about near-term earnings trajectory.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Falls 9.51% in Regular Trading, Fiscal Q3 Swings to Loss Exceeding Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Falls 9.51% in Regular Trading, Fiscal Q3 Swings to Loss Exceeding Expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-03 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 3, Twist Bioscience Corp declined 9.51% in regular trading, trading at approximately $87.2 per share, with turnover of $23.49 million. The selloff was triggered by the company's fiscal third-quarter earnings report showing a sharp swing from profit to loss.</p><p>The company reported a fiscal Q3 net loss of $0.56 per diluted share, swinging from earnings of $0.33 a year earlier. The loss exceeded the analyst consensus estimate of $0.51 per share. On the revenue side, the company posted $118.4 million, up 23.2% year-over-year, beating the $114.5 million estimate. The company also raised its full-year revenue outlook to $456-$457 million from a prior range of $442-$447 million, and guided fiscal Q4 revenue of $123-$124 million versus the $117.4 million consensus.</p><p>Despite strong top-line growth and upbeat forward guidance, the deterioration in profitability dominated investor sentiment. Additionally, Evercore ISI had downgraded the stock from Outperform to In Line in early July, reflecting prior concerns about near-term earnings trajectory.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1119962251","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119962251","pubTimestamp":1785764410,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 3, Twist Bioscience Corp declined 9.51% in regular trading, trading at approximately $87.2 per share, with turnover of $23.49 million. The selloff was triggered by the company's fiscal...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 常规交易下跌 9.51%，第三财季亏损超预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 3, Twist Bioscience Corp declined 9.51% in regular trading, trading at approximately $87.2 per share, with turnover of $23.49 million. The selloff was triggered by the company's fiscal third-quarter earnings report showing a sharp swing from profit to loss.The company reported a fiscal Q3 net loss of $0.56 per diluted share, swinging from earnings of $0.33 a year earlier. The loss exceeded the analyst consensus estimate of $0.51 per share. On the revenue side, the company posted $118.4 million, up 23.2% year-over-year, beating the $114.5 million estimate. The company also raised its full-year revenue outlook to $456-$457 million from a prior range of $442-$447 million, and guided fiscal Q4 revenue of $123-$124 million versus the $117.4 million consensus.Despite strong top-line growth and upbeat forward guidance, the deterioration in profitability dominated investor sentiment. Additionally, Evercore ISI had downgraded the stock from Outperform to In Line in early July, reflecting prior concerns about near-term earnings trajectory.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119962251","isCrawlerRequest":true}